ARISTADA
Live / Registered — Registered and renewed (as of 09 Feb 2026)
What this means for you
Registered since 26 Jan 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 Jan 2026).
Record
- Serial number
- 85619287
- Registration number
- 4893254
- Mark type
- Stylized text
- Filed
- 08 May 2012
- Published for opposition
- 23 Oct 2012
- Registered
- 26 Jan 2016
- Next maintenance due
- 26 Jan 2026
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
Owner
- ALKERMES PHARMA IRELAND LIMITED, Dublin 4, IE
- ALKERMES PHARMA IRELAND LIMITED, DUBLIN 4, IE
- ALKERMES PHARMA IRELAND LIMITED, DUBLIN 4, IE
- Alkermes, Inc., Waltham, MA, US
Prosecution history
- 09 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 09 Feb 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 09 Feb 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 09 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Nov 2025 — TEAS SECTION 8 & 9 RECEIVED
- 26 Jan 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 22 Jun 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Jun 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 22 Jun 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Jan 2022 — TEAS SECTION 8 & 15 RECEIVED
- 26 Jan 2016 — REGISTERED-PRINCIPAL REGISTER
- 23 Dec 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
- 22 Dec 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Dec 2015 — ASSIGNED TO EXAMINER
- 14 Dec 2015 — STATEMENT OF USE PROCESSING COMPLETE